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Class 11 MHC molecules (Ia) are transmembrane glycoproteins that function
as cell recognition structures during the initiation ofan antigen-specific immune
response (1). T lymphocytes of the helper-inducer lineage (Th cells) express
receptors that recognize foreign antigens in association with the la glycoproteins.
The binding ofthis complex ligand to the TCR is required for the activation of
Th cells, anessential step in the promotion ofantibody and cell mediated immune
responses. Although the sequences of many la alleles and TCR molecules are
now known (2, 3), the molecular details of the interaction that occurs between
Ia, foreign antigen and the Tcell receptor remains an enigma.
The murine Ia molecules, designated A (A~ As) and E (Ea E#), are transmem-
brane glycoproteins, each consisting ofa 33-kD a chain noncovalently associated
with a 29-kD 0 chain. Both the a and the 0 chains contain two extracellular
domains, designated a, and a2, (J, and 02, respectively (4). Sequence analysis of
allelic a and ,Q chain genes revealed that most polymorphic residues are located
in the NH2-terminal a, and ,#, domains (5-8). These polymorphicresidues, which
tend to be clustered in three or four regions of the primary structure of the
NH2-terminal domains, are believed to be responsible for determining allele
specific antibody binding sites and T cell recognition properties of the la
molecules (9-11).
Allospecific antisera and mAbsdirected against the la glycoproteins have been
important tools for the characterization of MHC alleles (HLA typing in the
human), H-2 recombinant mouse strains, and the biochemical purification of la
molecules (12-14). Since these reagents specifically block the activation of T
cells in antigen presentation assays, they have been used for evaluating la
structure-function relationships (15). Recently, therehas been increasing interest
in the use ofanti-la mAbs in an attempt to modulate the immune system and as
therapeutic reagents in certain autoimmune diseases (16-IS). Thus, the identi-
fication of residues comprising the Ia antigenic determinants will contribute to
the identification of the functionally important regions on the la molecule.
Several advances have been made toward identifying antibody binding sites
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on la antigens. The chain specificity of anti-la mAbs and the relationship of
different antibody binding sites have been addressed in the analysis of in vitro
immunoselected la bearing cell lines and L cells transfected with la genes (19-
23). Exon-shuffling experiments further mapped the binding sites of the various
A' reactive antibodies to the (3,-domain of the A, polypeptide (9). Recently,
antibody binding sites within the a, and /3, domains were investigated through
the useofcell lines expressing genes that contained a limited number of mutations
introduced by site-directed mutagenesis (11, 24, 25). These results, together
with the sequence analysis of the in vivo, spontaneous mutant bm 12 (26),
suggested that the residues in the polymorphic region around position 66 in the
(3, domain were involved in determining antibody binding sites on the Ia
molecule.
We have undertaken a comprehensive analysis of the structural basis of
antibody binding sites on the ,#, domain of the Aa and Ad polypeptides. We
constructed variant Ap genes that encoded single or multiple residues of the A'o
polypeptide at 14 polymorphic positions in the ,0, domain. The mutant 0 chain
polypeptides were expressed in combination with either the Ad or A.polypeptides
after transfection of genes into the B lymphoma cell line M12.C3. Analysis of
the transfected cell lines using a panel of Ap- and Ad-reactive mAbs has enabled
us to identify the polymorphic residues that are involved in determining these
antibody binding sites.
Materials and Methods
Oligonucleotides.
￿
The following oligonucleotides were used for mutagenesis: 5 CATT-
TCGTGGTCCAGTTC 3 (pos. 9); 5 CACCAGTTCAAGCCC 3 (pos.12); 5 GTTCCAGG-
GCTTCTG 3 (pos.13); 5 CCAGCCCGAGTGCTACT 3 (pos.14); 5 TGCTACTACACC-
AACGG 3 (pos. 17); 5 (CTTCTGACCAGATACA 3 (pos.28); 5TGCGCTACGACAGC 3
(pos.40); 5 ACTGGAATAGCCAGTACC 3 (pos.63); 5 GGAATAAGCAGCCGGAGAT-
CCTGGAGCGAA 3 (pos. 65-67); 5 GGCCGAGGTGGACACG 3 (pos.75); 5 GACAC-
GGCGTGCAGAC 3 (pos.78); 5 CTxCGAGGGGACGGAG 3 (pos.85); 5 CGAGAAGCC-
GAGA 3 (pos.86); 5 GAGACCAGCACCTCC 3 (pos.89); 5 TTTCGTGGTCCAGTTC-
AAGGCGAGTGCTACTACACCAAC 3 (regionA); 5ACTGGAATAGCCAGCCGGAG-
ATCCTGGAGCGA 3 (region B); 5 GGGCCGAGGTGGACACGGCGTGCAGACA 3
(region C); 5 CAACTACGAGGGGCCGGAGACCAGCACCTCCCT 3 (region D). The
oligonucleotide intended to change position 87 and region A were purchased from SYN-
TEK AB, Umea, Sweden, and used withoutfurtherpurification . Allother oligonucleotides
were synthesized with a DNA synthesizer (model 380A; Applied Biosystems, Inc., Foster
City, CA) using the phosphoramidite method and were purified by polyacrylamide gel
electrophoresis.
Mutagenesis.
￿
The method for site-directed mutagenesis used in this study was described
previously (27). The second exon of the A' gene was cloned into M13 mpIOam (Pharmacia
Fine Chemicals, Piscataway, NJ) after a partial digestion of Cos. 1 .1 (kindly provided by
Dr. Lee Hood, California Institute of Technology, Pasadena, CA) with the endonuclease
Xcy 1 . The M13 clone contained a 731-bp insert with two Sst II endonuclease restriction
sites closely flanking the second exon. The heteroduplex was formed using 2 wg ofSSDNA
from this clone together with 0 .5 jug of double-stranded M13 mp l Owild (Amersham
Corp., Arlington Heights, IL) that was double digested with the endonucleases Eco RI
and Sma I in the polylinker region. 2-30 nmol of each oligonucleotide were used to
introduce mutations and up to four different oligonucleotides were annealed to the
heteroduplex in a single reaction. Filters were lifted from plates containing foci ofinfected
MK-30 su-bacteria (all the bacterial strains required for the experiments were generously
provided by Dr. HansJoachim Fritz, Max-Planck Institute for Biochemistry, Martinsried,BUERSTEDDE ET AL.
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Federal Republic of Germany) and were hybridized with the mutagenic oligonucleotides.
M13 clones showing preferential hybridization were expanded and their entire second
exon of the AO gene was sequenced by the dideoxy chain termination method (28).
Construction of Mutant A#' Genes.
￿
Replicative form of M13 clones containing the
desired mutations was digested with endonuclease Sst 11 and ligated into an A' gene
construct that lacked the Sst 11 fragment. The A'# gene was originally cloned from the
Cos. 1 .1 into puc 18 as a 12-kb Hind III/Hpa I fragment. Recombinant bacterial colonies
were screened by an oligonucleotide that covers the Sst II site 5' to the second exon. The
uptake of only one Sst 11 second exon fragment was confirmed by a partial restriction
map of the isolated plasmids with endonuclease Sma 1. Before transfection preferential
hybridization of the mutant A# gene constructs with the mutagenic oligonucleotides was
checked by Southern blot analysis. The As1k gene was constructed by ligating the second
exon of A" contained in pCA 12 (provided by Dr. Lee Hood, California Institute of
Technology) into an Ak gene construct that had the second exon deleted by Sst 11
digestion.
DNA-mediated Gene Transfer ofM12.C3 Cells.
￿
The M12.C3 cell line, which was given
to us by Dr. Laurie Glimcher, Harvard University, Cambridge, MA, was grown in RPMI
1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% heat-
inactivated FCS, 100 U/ml penicillin, 100 wg/ml streptomycin, 2 MM L-glutamine, 0.1
mM 2-ME and buffered to pH 7 .3 with 10 mM Hepes. 5-10 x 106 cells were mixed with
40 jug of pRSVneo plasmid (29) that was linearized with the endonuclease Barn HI, 25 ug
of mutant Ag gene plasmid, and 40 jAg of Aa gene plasmid (both linearized with the
endonuclease Hind III) in 0.6 ml medium containing 140 mM NaCl, 25 mM Hepes, 0 .75
mM Na2HP04, pH 7.4 (the A. gene, a gift from Dr. Laurie Glimcher, was recloned into
puc 18 as a Hind III fragment). Electroporation (30, 31) was carried out at 480 V/cm
using the PDS Model ZA 1000 (Prototype Design Services, Madison, WI). The treated
cells were resuspended in 12 ml of the culture medium described above and distributed
to 12 wells ofa 24-well Costar (Cambridge, MA) plate. After 16 hr, 1 ml selective medium
(culture medium plus 600 Ag/ml G-418 (Gibco Laboratories) was added to each well. 2-
3 wk later G-418 resistant cells were subcloned by limiting dilution . Subclones were
screened using a cell ELISA (19) with mAbs reactive to A0 or A#. Positive subclones were
expanded for further analysis.
Quantitative Immunofuorescence.
￿
The mAbs used are listed in Tables I and IV. The
staining procedure has been described previously (19). All antibodies were used in form
of culture supernatants. FITC-protein A (Pharmacia Fine Chemicals) was the developing
reagent for IgG mAbs, and FITC-goat anti-mouse IgM (Meloy Laboratories Inc.,
Springfield, VA) for IgM mAbs. Control antibodies of the appropriate isotype were used
to quantitate nonspecific binding. Cytofluorometric analyses were measured on a logarith-
mic scale and peak channel values were subsequently converted to linear values for
calculating comparative immunofluorescence values.
Results
The Aa and AR polypeptides differ from each other by single amino acids at
13 positions in the 01 domain . In addition, the Ad polypeptide contains three
amino acids at positions 65, 66, and 67 (designated 65-67) compared with a
single amino acid present in the A' polypeptide (Fig. 1 a). Using site-directed
mutagenesis, we separately introduced codons characteristic of the d allele into
the A# gene sequence at each of the polymorphic positions (Fig. 1 b). The DNA
sequence of the second exon, which encodes residues 6-96 of the 01 domain was
determined for each of the mutant genes. The mutant As genes were cotrans-
fected with the wild-type Aa gene and a neomycin resistance gene into the B
lymphoma line M 12.C3 . As described previously, this B lymphoma line does not
express its endogeneous Ad molecule on the cell surface (32). The lack of Ad
expression results from the absence of AQ mRNA, although functional Ad mRNA476
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Aminoacid sequencesof theR, domain encodedby thewild-type A#'andA'#alleles
and mutant A0k genes (6, 8). (A) Sequence of the /3, domains of the As and Ad polypeptides as
deduced from the nucleotide sequences of the corresponding genes. (B) Sequences of the /3,
domains of the mutant Ak polypeptides containing residues of the A' polypeptide at single
positions. (C) Sequences of the S, domains of mutant A' polypeptides containing residues of
the A' polypeptide at multiple positions. The three sequences M76.89T, M51A.63.75, and
M12.51A.63.75 contain one additional substitution characteristic of neither the A'# or As
polypeptide. The assignment of amino acid positions was based on the sequence of the /3,
domain of the Ao'polypeptide, which is twoamino acids longer than thefl, domain of the Ai
polypeptide.
is present. After transfection, neomycin (G-418)-resistant bulk cell populations
were cloned by limiting dilution. Individual clones were tested by cytofluoro-
metric analysis to obtain cell lines that expressed similar levels of the mutant A'o
polypeptide with the Aa polypeptide on the cell surface. Since the Aa and A#
polypeptides preferentially associate with each other transfected M12.C3 cells
expressing the Ak3 polypeptideand high levels ofAk polypeptide express relatively
small amounts of the Aa As hybrid molecules. In contrast, cells transfected with
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TABLE I
Properties ofAf,--reactive mAbs
Chain specificity was determined previously (15, 19).
TABLE II
Cytofuorometric Analysis ofM12.C3 Cell Lines Transfected with Mutant As Genes that Encode
Residues of the Ad Polypeptide at Single Positions in the /31 domain
The transfected cell lines were divided into four categories based upon levels of antibody binding relative to the wild-type
TA3 cell line (20). The peak fluorescence channel difference between cells stained with the negative antibody and cells
stained with the antibody in question was divided through the peak channel difference obtained for the TA3 cell line with
the same antibodies in the same experiment and then multiplied by 100. (-) Values <5%; (+) values 5-25%; (++) values 26-
75%; (+++) values >75%.
* Cell line transfected only with the neomycin resistance gene.
t Cell line transfected with the wild-type Ae and Aa gene.
f 39J recognizes the A, polypeptide (19).
1 K24-199 recognizes the A; polypeptide.
the A,6 gene alone express high levels of the Ad Ak # hybrid molecules (data not
shown).
Loss ofAk k Epitopes.
￿
A panel of mAbs raised in different strain combinations
or showing different patterns of crossreactivity (Table I) was selected for this
analysis. The diverse origin of the antibodies was intended to maximize the
number ofpotentially different antibody binding sites that could be investigated.
As shown in Table II, the A,k e-reactive antibodies did not bind to cells transfected
with only the neomycin resistance gene (T.Neo), but didbind to cells transfected
with the wild-type Ak k gene together with the Aa gene (T.Ak). Among the 14 cell
lines that were transfected with mutant A,, chain genes, only those two that
expressed Ak k polypeptides containing amino acids of the Ad polypeptide at
positions 63 or65-67 showedcomplete loss ofantibody binding. The substitution
of serine for lysine at position 63 in the Ak k polypeptide eliminated binding of
mAb T.
Neo* T.A 4 T9 T12 T13 T14 T17
Cell
T28
lines
T40 T63 T65-67 T75 T78 T85 T86 T89
39B - ++t +++ +++ +++ ++ +++ +++ +++ +++ - +++ +++ ++ ++ t++
39E - ++t +++ t+t +++ ++ +t +++ +++ tt+ - +++ +t+ ++t +tt t+t
40M - +++ +++ +++ +++ ++ +++ +++ +++ +++ - +++ +++ +++ +++ +++
10.2-I6 - +++ +++ +++ +++ ++ ++ +++ ++ +++ - +++ +++ +++ ++ +++
11-3.25 - +++ +++ +++ +++ +++ +++ +++ +++ +++ - +++ +++ +++ +++ +++
4-2.1 - t++ +t+ t++ +++ ++ ++ +++ ++ +++ - +t+ +++ t++ +++ +++
4-2.3 - +++ +++ +++ ++ ++ +++ +++ +++ +++ - N.D. +++ ++ +++ +++
40F - +++ +++ +++ +++ ++ +++ +++ +++ - +++ +++ +++ +++ +++ +++
39J1 - +++ +++ ++ + ++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
K24-1991 - + - ++ + - - - - + - - - - - -
mAb Crossreactivity Strain combination Reference
39B I-Alr." (Ia.1) A.TH anti-A.TL 33
39E I-Alr.u (Ia.1) A.TH anti-A.TL 33
40M I-A"." (Ia.1) A.TH anti-A.TL 33
10-2.16 I-A" (Ia.17) CWB anti-C3H 34
11-3.25 I-Al.r.s (Ia.17) Balb/c anti-CKB 34
4-2.1 I-A". sj (Ia.17) BI OT anti-BIO.M 35
4-2.3 I-A"'i (Ia.18) BLOT anti-BIO.M 35
40F I-A" A.TH anti-A.TL 33478
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TABLE III
Cytofuorometric Analysis ofM12. C3 Cell Lines Transfected with Mutant A~ Genes that
Encode Residues oftheAd Polypeptide at Multiple Positions in the l31 Domain
The TA3 cell line was used as a standard (see under Fig. 1).
* 39J recognizes the Aa polypeptide.
antibody 40F, whereasthe substitution of the three amino acidsproline, glutamic
acid, and isoleucine for a single tyrosine at position 66 in the Ak ' polypeptide
eliminated the binding of those antibodies that define the allospecificities Ia.1 .
Ia.17, and Ia.18 (mAbs 39B, 39E, 40M, 10-2 .16, 11-3 .25, 4-2.1, 4-2.3). These
cytofluorometric analyses, which used saturating amounts of anti-Ia antibodies,
were designed to evaluate relative expression levels of cell surface Ia molecules.
Additional analyses will be needed to determine ifalterations in antibody binding
affinities have been introduced by these mutations in the ,Q1 domain . One of the
mutant clones (T14) expresses lower levels of A' molecules on the cell surface
than the TA3 cell line (Table II). Cytofluorometric analysis of the T14 bulk cell
population indicated this mutation did not result in significant qualitative alter-
ation of the Ak molecule and the Ak expression level on the clone is not
representative of most of the cells in the bulk population.
Multiple Amino Acid Alterations in the 01 Domain of the Ak k Polypeptide.
￿
The
technique of site-directed mutagenesis used in this study allowed us to simulta-
neously obtain mutations at several positions within the second exon of the Ak 0
gene by annealing multiple oligonucleotides in the same experiment. The (31
domain amino acid sequences encoded by these mutant genes are shown in Fig.
1c. Three genes in this series (M12.51A.63.78, M51A.63.78, and M78.897)
contained unintended nucleotide substitutions that changed the codons at posi-
tions 51 and 89 to condons found in neither the d nor the k allele . Cell lines
expressing the genes that encode changes at multiple positions in the (31 domain
were stained with Ak-reactive mAbs (Table III). Only those cell lines that
expressed Ap polypeptides containing amino acids characteristic of the A
d poly_
peptide at position 63 or 65-67 exhibited loss of binding with Ak #-reactive
antibodies. These results support the previous finding that among the residues
that differ between the A,3 and A,3 polypeptide only the residues at positions 63
and 65-67 determine the binding sites of the tested Ak-reactive antibodies.
Regional Changes in the 01 Domain of the Ak k Polypeptide.
￿
The polymorphic
residues within the 0] domain of the Ad and Ak '3 polypeptide cluster in stretches
mAbs
T9.17 T17.63 T65-67 .78
Cell
T9.17.63
lines
T78.87.T T51A.63.75 T12.51A.63.75
39B +++ ++ - +++ +++ +++ +++
39E +++ ++ - ND +++ +++ ND
40M +++ +++ - +++ +++ +++ +++
10.2-16 +++ ++ - +++ +++ +++ +++
11-3 .25 +++ +++ - +++ +++ +++ +++
4-2.1 +++ +++ - +++ +++ +++ +++
4-2.3 +++ ++ - +++ +++ +++ +++
40F +++ - ++ - +++ - -
39j* +++ +++ +++ +++ +++ +++ +++BUERSTEDDE ET AL.
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Sequences of the S, domain of the A' and Ad and
containing changes ofpolymorphic regions.
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of mutant A' # polypeptides
of the primary sequence (Fig. 2a). Based on this pattern, we divided the ,Q,
domain into four regions ofpronounced interallelic variability. The regions (Fig.
2a) encompass residues at position 9-17 (region - - A- .), 63-67 (region - - B- . ),
75-78 (region - -C ), and 85-89 (region D ). Sequencesencoding theamino
acids of the Ap polypeptide in these four regions were introduced into the A'O
gene by site-directed mutagenesis. Oligonucleotides corresponding to each of
the four regions were used simultaneously in a single mutagenesis reaction and
allowed the isolation of clones containing single as well as multiple mutations
(Fig. 2b).
Transfection of the wild-type Aa gene together with mutant Ak genes that
encode region --A of the Ad polypeptide did not result in cell surface
expression of la molecules containing the A', polypeptide as determined by
quantitative immunofluorescence analysis with A.-reactive mAbs (data not
shown). Staining of the transfected cells with an Ad .-reactive mAb (K24-199)
revealed that the mutant Ao polypeptides containing substitutions characteristic
of the d allele in region - -A- - were expressed on the cell surface in association
with the endogenous A« polypeptide of the M12.C3 cell line (Table IV). This
finding is in agreement with previous reports that the Ad polypeptide does not
associate with the A', polypeptide (36, 37) and that a region controlling a/,Q chain
association maps to the NH2-terminal half of the f3, domain (10, 38).
Cell lines expressing the mutant Ak polypeptides with regional changes in
combination with either the Aa polypeptide or, in the case of a substitution of
region A, in combination with the Ad polypeptide, were stained with the anti-
bodies reactive to A' (Table IV). All cell lines expressing Ak genes that encode
region B of the AO polypeptide did not react with any Arreactive antibodies.
Also of particular interest is the finding that the cell line expressing the gene
that encodes regions ACD of the Ad polypeptide retained binding of all Ap-
reactive antibodies. Substitutions of amino acids of theA# polypeptideat positions
28 and 40 also do not influence binding of the Ak reactive mAbs (Table II).
Together these findings clearly demonstrate immunodominance of the region B
of the A,3 polypeptide, showing the A# antibody binding sites are maintained
despite substitutions of all A# characteristic residues in the ,O, domain outside of
region B.
k GNSERHFVHQ FQPFCTFTNG TQRIRLVIRY IYNZEEYVRF DSDVGEYRAV IELGRPDAEY WNKQ Y LER TRAELDTVCR HNYEKTEIPT SLRRLE
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TABLE IV
Cytofluorometric Analysis ofM12. C3 Cell Lines Transfected with Mutant A~ Genes that
Encode Single or Multiple Regions of the Ad Polypeptide in the 0, Domain
TheTA3 cell line was used as a standard (see under Fig. 1).
* 39J recognizes the Aa polypeptide.
$ K24-199 recognizes the Aa polypeptide.
Gain ofAd Epitopes.
￿
To investigate the possibility that antibody binding sites
characteristic of the d allele have been introduced by the substitution of A,d e
residues into the Ak k3 polypeptide, eight different Ad-reactive antibodies were
tested for binding to the panel of transfected cell lines. Antibodies derived from
different strain combinations or showing different patterns of crossreactivity
were included (Table V). None of the Ad-reactive antibodies stained M12.C3
cells expressing the Ak ' polypeptide in combination with either the A' or Ad
polypeptide (designated T.Ak and T.AR, respectively, Table VI). In contrast, all
antibodies bound to transfected M12.C3 cells that expressed an A,' 91' hybrid gene
construct in which the second exon of the A,k e gene was replaced by the second
exon of the AQ gene (designated T.AIld, Table VI). This binding pattern dem-
onstrates that thebinding sites ofall of the Ad d-reactiveantibodies are determined
by polymorphic residues in the ,0, domain of the Ad polypeptide.
The Ad-reactive antibodies were first tested against the cell lines expressing
As genes that encoded regional changes. Antibodies 25-9-17S, 34-5-3S, Y-212,
Y-237, and Y-276boundto all thecell lines expressing the mutant A,kk polypeptide
containing region B residues of the Ad d polypeptide. These antibodies could
be further divided into three groups on the basis of the reactivity with the two
cell lines that express Ak ' polypeptides with changes at either position 63 or
positions 65-67. Antibody Y-212 stained the cell line expressing the mutant Aa
polypeptide containing serine at position 63 (T63), antibodies 25-9-17S, 34-5-
3S, and Y-237 stained the cell line expressing the mutant Ak k polypeptide that
contained proline, glutamic acid, and isoleucine at position 65-67 (T65-67) and
antibody Y-276 did not bind to either T63 or T65-67 cells. These results, which
were the reciprocal of those observed with the A,k e-reactive mAbs, demonstrate
that the presence of amino acids characteristic of the Ad polypeptide at positions
63 and 65-67 of the Ap polypeptide results in binding of most Ad #-reactive
antibodies tested.
Four exceptional cases were noted. Antibody MKD6 bound only to the cell
mAbs
T.A. T.B. T.C.
Cell lines
T.D. T.ABC T.ACD T.BCD
39B +++ - +++ +++ - +++ -
39E +++ - +++ +++ - +++ -
40M +++ - +++ +++ - +++ -
10.2-16 +++ - +++ +++ - +++ -
11-3 .25 +++ - +++ +++ - +++ -
4-2.1 +++ - +++ +++ - +++ -
4-2.3 +++ - +++ +++ - +++ -
40F +++ - +++ +++ - +++ -
39J* - +++ +++ +++ - - +++
K24-199$ +++ + - - +++ +++ -BUERSTEDDE ET AL.
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TABLE V
Properties ofA' reactive mAbs
TABLE VI
Cytofluorometric Analysis ofMutant As-bearing Cell Lines with Antibodies Reactive to A° d
The TA3 cell line was used as a standard (see under Fig. 1).
* Cell line transfected with the wild-type A; and Aa gene.
= Cell line transfected only with the wild-type Aa gene.
'F Cell line transfected with an AA gene construct in which the second exon was derived from the A% gene.
1 Cell line transfected only with the M40 Ap gene.
39J recognizes the Aa polypeptide.
** K24-199 recognizes Aa polypeptide.
lines expressing the mutant A' polypeptides containing regions - -ABC - - or
regions BCD of the Ad polypeptide (Table VI). Therefore, the epitope recog-
nized by this antibody is either determined by variable residues of regions
- -B- - and - -C- - or determined in a more complex fashion. A recent analysis
(38) of L cells transfected with Aa genes and various combinations ofhalf-exon-
shuffled A, 6 genes is consistent with these observations. Their results indicated
that although the binding of the MKD6 antibody to these exon-shuffled la
molecules was dependent upon the presence of d allele residues in the carboxyl
half of the al domain, polymorphic residues in both the N142-terminal half of
the 01 domain and in the Aa polypeptide influenced the binding affinity of the
MKD6 antibody. Antibodies Y-219 and Y-270, which did not stain any of the
cell lines expressing A' polypeptides with regional changes, did react with the
cell line expressing the mutant A' polypeptide containing tyrosine characteristic
ofthe As polypeptide at position 40 (Table VI). Binding was stronger to the cell
line expressing this mutant A'polypeptide in association with the Ad polypeptide
(T400) than to the cell line expressing the mutant As polypeptide predominantly
in association with the Aa polypeptide (T40). This result suggests thatthe binding
sites of the antibodies Y-219 and Y-270 may be influenced by polymorphic
residues on both the a and 0 chain polypeptides. The reactivity pattern of
mAbs T.A4* T.AP T.A°n'# T28 T40 T40,31 T63 T65 T.A T.B T.C T.D T.ABC TACD T.BCD
25-9-17S - - +++ - - - - ++ - +++ - - +++ - +++
34-5-3S - - +++ - - - - ++ - +++ - - +++ - +++
Y-212 - - +++ - + ++ +++ - - ++ - - + - +
Y-219 - - +++ - + ++ - - - - - - - - -
Y-237 - - +++ - - - - + - ++ - - ++ - +
Y-270 - - +++ - + +++ - - - - - - - - -
Y-276 - - +++ - - - - - - +++ - - +++ - +++
MKD6 - - +++ - - - - - - - - - ++ - ++
39Jj +++ - - ++t +++ - +++ +++ - +++ +++ +++ - - +++
K24-199** + ++ +++ - - +++ + - - + - - +++ +++ -
mAb Crossreactivity Strain combination Reference
25-9-17S I-Ab,p.a C3H anti-C3H .SW 39
34-5-3S I-Ab.p.9 C3H anti-BDFI 39
Y-212 I-Ab.p.q.'." A/J anti-BIO.A(5R) 23
Y-219 I-Ab,,.v A/J anti-BIO.A(5R) 23
Y-237 I-Ah.P'v." A/J anti-B10.A(5R) 23
Y-270 I-Ab.r'v A/J anti-BIO.A(5R) 23
Y-276 I-Ab.r.a.v A/J anti-BIO.A(5R) 23
MKD6 I-AP.a (B6 x AJ) anti-B10.D2 40482
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FIGURE 3. Quantitative immu-
nofluorescence profiles using
monoclonal antibody Y-212 illus-
trating representative levels of
cell surface la expression ob-
tained on cell lines transfected
with differentAa and/or A'0genes.
Categories of expression levels
used in Tables III, IV, V, andVII
are represented by: (-) T.A'# and
T65; (+)T40; (++) T400; (+++)
T.A°/dand T63.
antibody Y-212 differs from that observed with antibodies Y-219 and Y-270 in
that antibody Y-212 reacts with cells expressing dallele residues at either position
63 (T.63) or position 40 (T.40). Cells expressing the M.40 As polypeptide
associated with the Ad polypeptide (T.40#) react more strongly with Y-212 than
cells expressing the M.40 A' polypeptide associated with Ak (T.40) (Fig. 3).
However, antibody Y-212 did not bind stronger to cells expressing M.63 A#
polypeptide associated with the A. polypeptide than to cells expressing M.63 Aa
polypeptideassociated with theA.polypeptide (data not shown) . The observation
that the antibody binding site recognized by mAb Y-212 is determined by the
polymorphic residues at both positions 40 and63 suggests that these tworesidues
may be adjacent to each other in the three-dimensional conformation of the Ad
molecule.
Discussion
The extensive allelic structural diversity of la polypeptides determines the
unique components of allospecific antibody binding sites. Although allelic amino
acid variation in the 0, domain, and presumably the a, domain determine T cell
recognition as well as allospecific antibody binding (9, 10, 23), it has not been
possible to determine the significance of particular residues or regions within the
O, domain due to the high number of polymorphic residues encoded by the
naturally existing alleles. We have begun to address this question by producing
a panel of cell lines expressing mutant A' polypeptides that contain amino acid
substitutions characteristic of the d allele at single or multiple positions within
the (3, domain .
Analysis of this panel of cell lines with eight different A' reactive and eight
different Ad-reactive mAbs demonstrated that a limited number of polymorphic
residues within the ,0, domain determine the binding of these allospecific anti-
bodies. Amino acid substitutions characteristic of the Ad polypeptide at positions
63 and 65-67 in the A,3polypeptideresulted in theloss ofbindingof all antibodies
reactive to Ak. The introduction of amino acids of the A,3 polypeptide at positions
40, 63, and/or 65-67 resulted in the binding of most Ap-reactive antibodies.BUERSTEDDE ET AL.
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These results suggest that the binding sitesof these A'-and As-reactive antibodies
are determined by the polymorphic amino acids at positions 40, 63, and 65-67.
Results from previous studies have indicated that certain amino acid substitu-
tions in the polymorphic region around positions 63 and 65-67 result in the loss
of antibody binding sites on the A, 3 chain. Substitution of three amino acids at
positions 67, 70, and 71 in the A, polypeptide resulted in the loss of multiple
allospecificities in the mutant mouse strain bm12 (26, 41). Similarly, five immu-
noselected mutant Ia-bearing cell lines exhibiting defects in many of the A,k e
antibody binding sites, contained single base substitutions in theirAs genes which
led to amino acid changes at positions 59, 64, or 70 (21, 42). Analysis of three
cell lines transfected with mutant As genes encoding Ak 'O characteristic residues at
positions 9, 13, or 65-67 revealed that only the change at position 65-67
resulted in loss of antibody binding sites characteristic of the Ab polypeptide (24).
These studies were limited, however, because only the loss of antibody binding
was observed and only the effects resulting from alteration of a small portion of
the ,0, domain was evaluated.
There remains the possibility that the antibody binding sites on the Ak ' and
A# polypeptides are not located at the polymorphic residues at positions 40, 63,
and 65-67. The amino acid substitutions at these positions could change the
conformation of the binding sites located in different parts of the Ak or Ad
molecule by allosteric effects. However, we do not favor this interpretation . The
regions around the residues at positions 40, 63, and 65-67 contain multiple
charged residues and are predicted (data not shown) to be markedly hydrophilic
according to a previously described algorithm (43). Consequently, these regions
are expected to be exposed on the surface of the molecule. In addition, single
or multiple substitutions of amino acids at other polymorphic positions in the (3,
domain of the Ap polypeptide do not measurably alter antibody binding sites.
Preliminary results indicate that substitutions of Ad characteristic residues in
either the NH2- or COOH-terminal part of the Ak 0, domain impair the ability
of the mutant Aa polypeptide to be expressed with either the Aa or Ad 3 polypeptide
(our unpublished results). Thus, the polymorphic residues in the NH2- and
COOH-terminal part of the A,e chain may be located near polymorphic residues
of the Aa chain and may not be sufficiently exposed at the surface of the molecule
to provoke a strong antibody response. A similar hypothesis was formulated by
Braunstein and Germain (38) from analyses of L cells expressing A# polypeptides
encoded by half-exon-shuffled genes. Their results suggested that the poly-
morphic residues in the NH2-terminal half of the ,Q, domain determines the
allele-specific a/achain pairing, whereas the polymorphic residues in the 000H-
terminal half of the a, domain determine the antigenic determinants recognized
by most A#-reactive antibodies. Finally, the observed gain of binding sites for the
Ad antibodies by substitution of d allele residues at positions 40, 63, or 65-67
parallels the observed crossreactivity patterns on known Ia alleles. For example,
antibodies Y-219 and Y-270, which react with T.40 cells, crossreact on the alleles
b, d, r, and v, but not on alleles, f, k, q, s, u, and p. Alleles b and d both have a
tyr at position 40 while alleles f, k, q, s, and, u have a phe at position 40 (alleles
r, v, and p have not been sequenced) . Similar comparisons are observed for
antibodies 29-9-175, 34-535, Y-237, and Y-276. These results suggest that each484
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of these antibody binding sites is determined primarily by one polymorphic
residue or a limited numberofpolymorphic residues on each crossreactingallele.
The analysis of allospecific antibody binding sites presented here is limited to
those residues that differ between the As and As polypeptide. It has previously
been shown that other residues in addition to the polymorphic residues that we
have identified influence the binding of certain Ak s-reactive mAbs. For example,
sequence analysis of genes encoding five different mutant As polypeptides,
selected with A' reactive mAbs for altered antibody binding properties, revealed
thatsubstitutions ofnonpolymorphic residues adjacent to the polymorphicregion
around positions 63 and 65-67 can also affect the conformation of the binding
sites recognized by these Ak k-reactive antibodies (21, 42). Moreover, polymorphic
residues other than those located at positions 40, 63, and 65-67 may influence
the binding of some of the tested mAbs. For example, mAbs 39B, 39E, 40M,
and 40F, whose binding to the Ak k polypeptide is lost after substitution of the
residues at positions 63 or 65-67, do not bind to the As polypeptide, although
this allele shares amino acids from position 62-69 and at position 40 with the
Ak # polypeptide (8, 33). This example demonstrates that in comparisons ofalleles
exhibiting multiple amino acid differences it is difficult to identify which amino
acids determine antibody binding sites solely on the basis of crossreactivity
patterns and sequence data.
The physiologic significance of la antigens stems from their role as restriction
elements for helper T cells. Recent studies indicate that T cell recognition of la
molecules is influenced by polymorphic residues on both a and ,B polypeptides
(10) and by residues in different regions of the a, domain (24, 44). In contrast,
most allospecific antibody binding sites on la molecules are determined by either
the a or (3 polypeptides, and as we have shown here, only a limited number of0,
polymorphic residues are involved in determining these sites. However, the
results of the assays used to identify T cell recognition sites are affected by at
least two potentially different regions on the la molecule, regions that bind la
antigen and regions that bind the T cell receptor. Analysis of this panel of
mutant Ak-expressing cell lines with Ak- or Ad-restricted T lymphocytes that
exhibit specificity for defined peptide antigens together with binding analyses
with labeled peptides to isolated mutant Ak molecules should facilitate the
characterization of the complex molecular interactions that occur between la,
processed antigen, and the TCR.
Summary
To identify which polymorphic residues determine the allospecific antibody
binding sites on As polypeptides, mutant A' genes were constructed encoding
single or multiple amino acids of the d allele at 14 polymorphic positions in the
,Q, domain. Cell lines expressing these genes were analyzed by quantitative
immunofluorescence using 16 mAbs reactive to Ak k or As. Substitution ofd allele
residues at positions 63 and 65-67 in the A' polypeptide resulted in the loss of
binding ofall Ak-reactive antibodies and the gain ofbinding ofmost As-reactive
antibodies. Two As-reactive mAbs bound to the mutant As s polypeptide contain-
ing d allele-characteristic residue at position 40. In contrast, substitution of theBUERSTEDDE ET AL.
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other polymorphic residues in the NH2-terminal and COOH-terminal regions of
the ,Q, domain did not alter antibody binding.
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David Sachs, Michel Pierres, Jeff Frelinger, and Norbert Koch for providing the mAbs;
and Steffan Ho for continuous interest and helpful discussions.
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